GIL 2026 | Frost & Sullivan awards Chengdu Shibekang the 2026 Frost & Sullivan Global Cardiovascular, Respiratory and New Drug Development Annual Company Award

2026/08/19

GIL 2026 | 沙利文授予成都施贝康2026年沙利文全球心脑血管及呼吸新药研发年度公司奖
GIL 2026 | Frost & Sullivan awards Chengdu Shibekang the 2026 Frost & Sullivan Global Cardiovascular, Respiratory and New Drug Development Annual Company Award